Cells · 2022 · 16 citations · 52 references
Life SciencesMolecular BiologyOncologyCancer PharmacologyDna RepairMolecular OncologyApoptosis In CancerCancer Genomic InstabilityDna Damage SignalingDna Damage-induced ApoptosisOvarian CancerOvarian Cancer PharmacotherapyAtr Signaling PathwayBrca MutationsDna Damage Response InhibitorsDna Damage Response PathwaysHomologous Recombination RepairOlaparib TherapyParp InhibitionPoly Adp-ribose Polymerase Inhibitors
Olaparib is a poly (ADP-ribose) polymerase inhibitor (PARPi) that inhibits PARP1/2, leading to replication-induced DNA damage that requires homologous recombination repair. Olaparib is often insufficient to treat BRCA-mutated (BRCAMUT) and BRCA wild-type (BRCAWT) high-grade serous ovarian carcinomas (HGSOCs). We examined the short-term (up to 48 h) efficacy of PARPi treatment on a DNA damage response pathway mediated by ATR and CHK1 kinases in BRCAMUT (PEO-1) and BRCAWT (SKOV-3 and OV-90) cells. The combination of ATRi/CHK1i with PARPi was not more cytotoxic than ATR and CHK1 monotherapy. The combination of olaparib with inhibitors of the ATR/CHK1 pathway generated chromosomal abnormalities, independent on BRCAMUT status of cells and formed of micronuclei (MN). However, the beneficial effect of the PARPi:ATRi combination on MN was seen only in the PEO1 BRCAMUT line. Monotherapy with ATR/CHK1 inhibitors reduced BrdU incorporation due to a slower rate of DNA synthesis, which resulted from elevated levels of replication stress, while simultaneous blockade of PARP and ATR caused beneficial effects only in OV-90 cells. Inhibition of ATR/CHK1 increased the formation of double-strand breaks as measured by increased γH2AX expression at collapsed replication forks, resulting in increased levels of apoptosis. Our findings indicate that ATR and CHK1 inhibitors provoke premature mitotic entry, leading to genomic instability and ultimately cell death.
52
Inhibition of Poly(ADP-Ribose) Polymerase in Tumors from <i>BRCA</i> Mutation Carriers
Peter C.C. Fong, David S. Boss, Timothy A. Yap et al. · New England Journal of Medicine · 2009 · 3.6K citations · Full text
Medicine, Oncology, Pharmacology +17
Cytokinesis-block micronucleus cytome assay
Michael Fenech · Nature Protocols · 2007 · 2K citations · Full text
Spheroid Chromatin Units (ν Bodies)
Ada L. Olins, Donald E. Olins · Science · 1974 · 1.4K citations